Alzamend Neuro completed its first Phase 2 trial for AL001, a novel lithium therapy aiming for better brain delivery and ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Licensed as a psychiatric nurse practitioner more than 20 years ago, I thought I’d never need or want to prescribe lithium. Old school, I thought. A 1950s drug; we have much better now. It’s true, ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...

A new study has found that early treatment with lithium can restore brain function and alleviate behavioral symptoms in mouse models of autism spectrum disorder (ASD) stemming from mutations in the ...

Britney Spears appeared in court in Los Angeles on 23 June to contest the 13-year conservatorship she has been placed under. In a 24-minute long statement, the 39-year-old told the court: “I’ve been ...

Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will be the principal investigator of the study Head-to-head study of AL001 versus a marketed lithium carbonate product will be ...